USANA Health Sciences, Inc. (NYSE:USNA) Director Sells $25,454.25 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller sold 675 shares of the company’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Gilbert A. Fuller also recently made the following trade(s):

• On Wednesday, August 7th, Gilbert A. Fuller sold 674 shares of USANA Health Sciences stock. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06.

USANA Health Sciences Stock Performance

Shares of USANA Health Sciences stock opened at $40.33 on Thursday. The company has a market cap of $768.37 million, a P/E ratio of 14.25, a PEG ratio of 1.29 and a beta of 0.89. USANA Health Sciences, Inc. has a one year low of $34.15 and a one year high of $54.81. The firm has a fifty day moving average of $37.53 and a two-hundred day moving average of $42.07.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same quarter in the prior year, the firm earned $0.59 EPS. As a group, equities analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently commented on USNA. DA Davidson reduced their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating for the company in a research report on Wednesday, October 23rd. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th.

Hedge Funds Weigh In On USANA Health Sciences

A number of large investors have recently made changes to their positions in the stock. Pzena Investment Management LLC increased its holdings in shares of USANA Health Sciences by 24.4% in the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock valued at $44,183,000 after purchasing an additional 191,289 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of USANA Health Sciences by 0.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock valued at $30,907,000 after purchasing an additional 3,889 shares in the last quarter. Pacer Advisors Inc. increased its holdings in shares of USANA Health Sciences by 14.3% in the 2nd quarter. Pacer Advisors Inc. now owns 467,352 shares of the company’s stock valued at $21,143,000 after purchasing an additional 58,597 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of USANA Health Sciences by 12.3% in the 2nd quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock valued at $7,229,000 after purchasing an additional 17,460 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its holdings in shares of USANA Health Sciences by 13.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after purchasing an additional 14,756 shares in the last quarter. Hedge funds and other institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.